ロード中...

Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

RTTNews | 306日前

Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

(RTTNews) - Amgen, Inc. (AMGN) announced Monday the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.

The nearly 300,000-square-foot facility will employ 400 full-time staff. It also features open workspaces to foster collaboration and has been designed to meet the highest environmental sustainability standards, in support of Amgen's commitment to achieve carbon neutrality for all operations by 2027.

In partnership with Columbus State Community College, Amgen is hosting an inaugural 18-month manufacturing apprenticeship at the site. This program, designed for those new to the field or changing careers, offers a blend of classroom and practical training, aiming to expand opportunities for skilled individuals without the requirement for a formal bachelor's degree.

タグ: AMGN

read more

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 212日前

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

RTTNews | 368日前

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 484日前

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 858日前

TSX Ends Modestly Lower

TSX Ends Modestly Lower

https://money.tmx.com/canadian-markets https://www.rttnews.com/3499633/bay-street-likely-to-open-slightly-higher.aspx?type=cn

RTTNews | 21時43分前

Dollar Turns In Mixed Performance Against Major Counterparts

Dollar Turns In Mixed Performance Against Major Counterparts

The U.S. dollar turned in a mixed performance against its major counterparts with traders assessing the Federal Reserve's likely moves with regard to interest rates next year.

RTTNews | 22時12分前

U.S. Stocks Close Notably Lower; Nasdaq Sheds 1.5 Percent

U.S. Stocks Close Notably Lower; Nasdaq Sheds 1.5 Percent

U.S. stocks tumbled on Friday and the major averages all closed notably lower with the tech-laden Nasdaq suffering a more pronounced loss as yields on 10-Year Treasury Note rose to near 8-month high.

RTTNews | 22時51分前

U.S. Stocks Down Firmly In Negative Territory; Nasdaq Tumbled 1.7 Percent

U.S. Stocks Down Firmly In Negative Territory; Nasdaq Tumbled 1.7 Percent

U.S. stocks are down firmly in negative territory Friday afternoon with rising Treasury yields contributing to the weakness. The major averages are all down in the red with the Nasdaq suffering a more pronounced loss.

RTTNews | 1日前

利用規約 | プライバシー | サイトマップ | Site Map Calendar

© 2024 Myfxbook Ltd。全著作権所有。

ハイリスクの警告：外国為替取引にはハイリスクが伴っているので、全ての人に適しているとは限りません。レバレッジは、追加のリスクと損失のエクスポージャーを生み出します。外国為替取引を決定する前に、あなたの投資目的、経験レベル、リスク許容度を慎重に検討してください。初期投資の一部及びその全ての失う可能性があるので、必要最低限以上のお金は投資しないでください。外国為替取引に関連するリスクについては、自分自身で学んで質問がある場合は独立した財務や税務顧問に質問してください。データと情報は全て'そのままの形'で提供されます。それらは情報提供のみを目的としており、取引目的やアドバイスを目的としたものではありません。過去の実績は、将来の結果を示すものではありません。